{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:07:19Z","timestamp":1751083639900,"version":"3.41.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1023\/a:1020587123523","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T20:12:43Z","timestamp":1048018363000},"page":"223-234","source":"Crossref","is-referenced-by-count":4,"title":["Interleukin-1\u03b1 Increases the Preferential Cytotoxicity of an Interleukin-2\u2013Diphtheria Toxin Fusion Protein Against Neoplastic Lymphocytes from Patients with the Sezary Syndrome Compared to Normal Lymphocytes"],"prefix":"10.1007","volume":"18","author":[{"given":"Dominique","family":"Salard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Kuzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Samuelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouahid","family":"Bakouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"409051_CR1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1200\/JCO.1991.9.7.1298","volume":"9","author":"TM Kuzel","year":"1991","unstructured":"Kuzel TM, Roenigk HH Jr, Rosen ST: Mycosis fungoides and the Sezary syndrome: A review of pathogenesis, diagnosis, and therapy. J Clin Oncol 9:1298\u20131313, 1991","journal-title":"J Clin Oncol"},{"key":"409051_CR2","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V79.10.2547.bloodjournal79102547","volume":"79","author":"CF LeMaistre","year":"1992","unstructured":"LeMaistre CF, Meneghetti C, Rosenblum M, Reuben J, Parker K, Skaw J, Deisseroth A, Woodworth T, Parkinson DR: Phase I trial of an IL2 fusion IL2-toxin (DAB486IL2) in hematologic malignanciers expressing the IL2 receptor. Blood 79:2547\u20132554, 1992","journal-title":"Blood"},{"key":"409051_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10428199309067928","volume":"11","author":"TM Kuzel","year":"1993","unstructured":"Kuzel TM, Rosen ST, Gordon LI, Winter J, Samuelson E, Kaul K, Roenigk HH Jr, Nylen P, Woodworth T: Phase I trial of the diphtheria toxin\/interleukin-2 fusion protein DAB486IL2: Efficacy iun mycosis fungoides and other non-Hodgkin's lymphomas. Leukemia Lymphoma 11:369\u2013377, 1993","journal-title":"Leukemia Lymphoma"},{"key":"409051_CR4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1200\/JCO.1993.11.9.1682","volume":"11","author":"P Hesketh","year":"1993","unstructured":"Hesketh P, Caguio P, Koh H, Dewey H, Facada A, McCaffrey R, Parker K, Nylen P, Woodworth T: Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma. J Clin Oncol 11:1682\u20131690, 1993","journal-title":"J Clin Oncol"},{"key":"409051_CR5","first-page":"137a","volume":"82","author":"CF LeMaistre","year":"1993","unstructured":"LeMaistre CF, Kuzel TM, Foss F, Hesketh P, Saleh M, Platanias L, Schwarz G, Craig F, Tolson K, Woodworth T: DAB389IL2 is well tolerated at doses inducing response in IL2-receptor expressing lymphomas. Proc Am Soc Hematol Blood 82:137a, 1993","journal-title":"Proc Am Soc Hematol Blood"},{"key":"409051_CR6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/protein\/1.6.493","volume":"1","author":"DP Williams","year":"1987","unstructured":"Williams DP, Parker K, Bacha P, Bishai W, Borowski M, Genbauffe F, Strom TB, Murphy JR: Diphtheria toxin receptor binding domain substitution ith interleukin-2: Genetic construction and properties of dipheterial toxin-related interleukin-2 fusion protein. Prot Eng 1:493\u2013498, 1987","journal-title":"Prot Eng"},{"key":"409051_CR7","doi-asserted-by":"crossref","unstructured":"Woodworth T, Nichols J: recombinant fusion toxins-a new class of targeted biologic therapeutics. In Cancer Treatment and Research: Immunoconjugate Therapy of Hematologic Malignancies, ST Rosen, TM Kuzel (eds), 1993, pp 145\u2013160","DOI":"10.1007\/978-1-4615-3076-3_8"},{"key":"409051_CR8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.154.5.1455","volume":"154","author":"RJ Robb","year":"1981","unstructured":"Robb RJ, Munck A, Smith KA: T-cell growth factor receptors: Quantitation, specificity and biologic relevance. J Exp Med 154:1455\u20131474, 1981","journal-title":"J Exp Med"},{"key":"409051_CR9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.3095922","volume":"234","author":"M Sharon","year":"1987","unstructured":"Sharon M, Kausner RD, Cullen BR, Chizzonite R, Leonard WJ: Novel interleukin-2 receptor subunit detected by cross-linking under high affinity conditions. Science 234:859, 1987","journal-title":"Science"},{"key":"409051_CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.1631559","volume":"257","author":"T Takeshita","year":"1992","unstructured":"Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K: Cloning of the gamma chain of the human IL2 receptor. Science 257:379\u2013382, 1992","journal-title":"Science"},{"key":"409051_CR11","doi-asserted-by":"crossref","first-page":"11885","DOI":"10.1016\/S0021-9258(19)38482-0","volume":"265","author":"DP Williams","year":"1990","unstructured":"Williams DP, Snider CE, Strom TB, Murphy JR: Structure\/function analysis of Interleukin-2-Toxin (DAB486IL-2). J Biol Chem 265:11885\u201311889, 1990","journal-title":"J Biol Chem"},{"key":"409051_CR12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0092-8674(89)90607-7","volume":"59","author":"M Hatakeyama","year":"1989","unstructured":"Hatakeyama M, Mori H, Doi T, Taniguchi T: A restricted cytoplasmic region of IL-2 receptor \u03b2 chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59:837\u2013845, 1989","journal-title":"Cell"},{"key":"409051_CR13","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830240902","volume":"24","author":"A Hemar","year":"1994","unstructured":"Hemar A, Lieb M, Subtil A, DiSanto JP, Dautry-Varsat A: Endocytosis of the beta chain of interleukin-2 receptor requires neither interleukin-2 nor the gamma chain. Eur J Immunol 24:1951\u20131955, 1994","journal-title":"Eur J Immunol"},{"key":"409051_CR14","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.4049\/jimmunol.145.7.2177","volume":"145","author":"S Minamoto","year":"1990","unstructured":"Minamoto S, Hatakeyama M, Kono T, Doi T, Ide T, Uede T, Taniguchi T: Characterization of the heterotrimeric complex of human IL-2 receptor alpha.beta chains reconstituted in a mouse fibroblast cell line, L929. J Immunol 145:2177\u20132182, 1990","journal-title":"J Immunol"},{"key":"409051_CR15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/eji.1830200412","volume":"20","author":"CA Waters","year":"1990","unstructured":"Waters CA, Schimke PA, Snider CE, Itoh K, Smith KA, Nichols JC, Strom TB, Murphy JR: Interleukin-2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells. Eur J Immunol 20:755\u2013791, 1990","journal-title":"Eur J Immunol"},{"key":"409051_CR16","first-page":"2590","volume":"56","author":"GG Waters","year":"1996","unstructured":"Waters GG, Poisson L, Willingham MC, Sugamura K, Frankel AE: Interleukin 2 (IL-2) receptor expression and sensitivity to diphtheria fusion toxin DAB389IL-2 in cultured hematopoietic cells. Cancer Res 56:2590\u20132595, 1996","journal-title":"Cancer Res"},{"key":"409051_CR17","doi-asserted-by":"crossref","first-page":"12145","DOI":"10.1074\/jbc.271.21.12145","volume":"271","author":"JC Vanderspek","year":"1996","unstructured":"Vanderspek JC, Sutherland JA, Ratnarathorn M, Howland K, Ciardelli TL, Murphy JR: DAB389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-recpetor interactions. J Biol Chem 271:12145\u201312149, 1996","journal-title":"J Biol Chem"},{"key":"409051_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1084\/jem.167.2.612","volume":"167","author":"P Bacha","year":"1988","unstructured":"Bacha P, Williams DP, Waters C, William JM, Murphy JR, Strom T: Interleukin-2 receptor targeted cuyptoxicity: Interleukin-2 receptor-mediated action of diphtheria IL2-toxin related IL-2 fusion protein. J Exp Med 167:612\u2013622, 1988","journal-title":"J Exp Med"},{"key":"409051_CR19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/protein\/4.4.463","volume":"4","author":"T Kiyokawa","year":"1991","unstructured":"Kiyokawa T, Williams DP, Snider CE, Strom TB, Murphy JR: Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells. Protein Eng 4:463\u2013468, 1991","journal-title":"Protein Eng"},{"key":"409051_CR20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0065-2776(08)60844-5","volume":"42","author":"KA Smith","year":"1988","unstructured":"Smith KA: The interleukin-2 receptor. Adv Immunol 42:165\u2013179, 1988","journal-title":"Adv Immunol"},{"key":"409051_CR21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1084\/jem.171.5.1509","volume":"171","author":"MA Caliguri","year":"1990","unstructured":"Caliguri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J: Functional consequences of interleukin-2 receptor expression on resting human lymphocytes: Identification of a novel natural killer cell subset with high affinity receptor. J Exp Med 171:1509\u20131526, 1990","journal-title":"J Exp Med"},{"key":"409051_CR22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.3008337","volume":"232","author":"TA Waldmann","year":"1986","unstructured":"Waldmann TA: The structure, function and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 232:727\u2013732, 1986","journal-title":"Science"},{"key":"409051_CR23","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","volume":"77","author":"CA Dinarello","year":"1991","unstructured":"Dinarello CA: Intereleukin-1 and interleukin-1 antagonism. Blood 77:1627\u20131652, 1991","journal-title":"Blood"},{"key":"409051_CR24","first-page":"1208","volume":"20","author":"S Ruhl","year":"1992","unstructured":"Ruhl S, Schwabe M, Pluznic DH: Interleukin-1 augments the expression of the interleukin-2 receptor alpha chain in interleukin-6 stimulated myeloid cells by a transcriptional and post-transcriptional mechanism. Exp Hematol 20:1208\u20131215, 1992","journal-title":"Exp Hematol"},{"key":"409051_CR25","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4049\/jimmunol.145.10.3340","volume":"145","author":"G Plaetinck","year":"1990","unstructured":"Plaetinck G, Combe MC, Corthesy P, Sperisen P, Kanamori H, Honjo T, Nabholz M: Control of the IL-2 receptor \u03b1 chain expression by IL-1, tumor necrosis factor and IL-2. J Immunol 145:3340\u20133347, 1990","journal-title":"J Immunol"},{"key":"409051_CR26","first-page":"471","volume":"93","author":"S Panzer","year":"1993","unstructured":"Panzer S, Madden M, Matsuki K: Interaction of IL-1 \u03b2, IL-6, and tumor necrosis factor \u03b1 in human T-cells activated by murine antigens. J Immunol 93:471\u2013478, 1993","journal-title":"J Immunol"},{"key":"409051_CR27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1992.10.7.1141","volume":"10","author":"IL Smith","year":"1992","unstructured":"Smith IL, Urba JV, Curti BD, Elwood LJ, Steis RG, Janik JE, Sharfman WH, Miller IL, Fenton RG, Conlon KC, Sznol M, Creekmore SP, Wells NF, Ruscetti FW, Keller JR, Hestdal K, Shimizu M, Rossio J, Alvord WG, Oppenheim JJ, Longo DL: The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignanciers. J Clin Oncol 10:1141\u20131152, 1992","journal-title":"J Clin Oncol"},{"key":"409051_CR28","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.4049\/jimmunol.153.6.2671","volume":"153","author":"KM Morrey","year":"1994","unstructured":"Morrey KM, McLachlan JA, Serkin DC, Bakouche O: Activation of human monocytes by the pineal hormone melatonin. J Immunol 153:2671\u20132680, 1994","journal-title":"J Immunol"},{"key":"409051_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mossmann","year":"1993","unstructured":"Mossmann T: Rapid colorimeric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363, 1993","journal-title":"J Immunol Methods"},{"key":"409051_CR30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1084\/jem.160.4.1126","volume":"160","author":"RJ Robb","year":"1984","unstructured":"Robb RJ, Greene WC, Risk GM: Low and high affinity cellular receptors for interleukin-2: Implications for the level of Tac antigen. J Exp Med 160:1126\u20131146, 1984","journal-title":"J Exp Med"},{"key":"409051_CR31","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI111379","volume":"73","author":"TA Waldmann","year":"1984","unstructured":"Waldmann TA, Greene WC, Sarin PS, Saxinger C, Blayney DW, Blattner WA, Goldman CK, Bongiovanni K, Sharrow S, Depper JM: Functional and phenotypic comparison of human T-cell leukemia\/lymphoma virus negative Sezary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human recptor for T-cell growth factor. J Clin Invest 73:1711\u20131718, 1984","journal-title":"J Clin Invest"},{"key":"409051_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1126\/science.2785715","volume":"244","author":"M Hatakayama","year":"1989","unstructured":"Hatakayama M, Tsudo M, Minatomo S, Kono T, Doi T, Miyata T, Miyasaka M, Taniguchi T: Interleukin-2 receptor beta chain gene: Generation of three receptor forms by cloned human alpha and beta chain cDNAs. Science 244:551\u2013556, 1989","journal-title":"Science"},{"key":"409051_CR33","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/eji.1830231221","volume":"23","author":"RK Furse","year":"1993","unstructured":"Furse RK, Malek TR: Selection of internalization-deficient cells by interleukin-2 pseudomonas exoIL-2 toxin chimeric protein: The cytoplasmic domain of the interleukin-2 receptor beta chain does not contribute to internalization of interleukin-2. Eur J Immunol 23:3181\u20133188, 1993","journal-title":"Eur J Immunol"},{"key":"409051_CR34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(78)90099-5","volume":"15","author":"M Yamaizumi","year":"1978","unstructured":"Yamaizumi M, Mekada E, Uchida T, Okada Y: One molecule of diphtheria IL-2 toxin fragment A introduced into a cell can kill the cell. Cell 15:245\u2013250, 1978","journal-title":"Cell"},{"key":"409051_CR35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/smim.1993.1037","volume":"5","author":"M Nakamura","year":"1993","unstructured":"Nakamura M, Asao H, Takeshita T, Sugamara K: Interleukin-2 receptor heterodimer complex and intracellular signalling. Semin Immunol 5:309\u2013317, 1993","journal-title":"Semin Immunol"},{"key":"409051_CR36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1146\/annurev.bi.58.070189.004303","volume":"58","author":"TA Waldmann","year":"1989","unstructured":"Waldmann TA: The multi-subunit interleukin-2 receptor. Annu Rev Biochem 58:875\u2013911, 1989","journal-title":"Annu Rev Biochem"},{"key":"409051_CR37","first-page":"409","volume":"3","author":"D Weil","year":"1988","unstructured":"Weil D, Dautry F: Induction of tumor necrosis factor \u03b1 and \u03b2 and interferon \u03b3 mRNA by interleukin 2 in murine lymphocytic cell lines. Oncol Res 3:409\u2013414, 1988","journal-title":"Oncol Res"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020587123523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1020587123523\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020587123523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T13:41:24Z","timestamp":1751031684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1020587123523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["409051"],"URL":"https:\/\/doi.org\/10.1023\/a:1020587123523","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}